Skip to Main Content

Paper Details

Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.
Neuro Oncol
26
2020
GBM, ICI, Patients, extravascular, glioblastoma, patients, rADC, rCBV, recurrent, tumor
Author NameAffiliation
Benjamin M Ellingsonuniversity of california los angeles Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles
Benjamin M Ellingsonuniversity of california los angeles Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles
Kambiz Naeluniversity of california los angeles Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles
  • 1 - 3

Datasets

Release 1.2